Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
INSY [NASD]
INSYS Therapeutics, Inc.
Index- P/E27.48 EPS (ttm)1.41 Insider Own0.50% Shs Outstand34.96M Perf Week0.47%
Market Cap1.35B Forward P/E23.27 EPS next Y1.67 Insider Trans63.67% Shs Float10.71M Perf Month0.96%
Income52.70M PEG0.98 EPS next Q0.34 Inst Own40.40% Short Float64.61% Perf Quarter9.22%
Sales195.80M P/S6.92 EPS this Y181.00% Inst Trans20.41% Short Ratio14.49 Perf Half Y47.68%
Book/sh4.19 P/B9.25 EPS next Y48.00% ROA37.70% Target Price52.25 Perf Year45.24%
Cash/sh1.80 P/C21.57 EPS next 5Y28.00% ROE47.60% 52W Range20.52 - 57.91 Perf YTD50.14%
Dividend- P/FCF51.71 EPS past 5Y16.10% ROI52.10% 52W High-33.09% Beta1.35
Dividend %- Quick Ratio2.30 Sales past 5Y- Gross Margin88.80% 52W Low88.84% ATR2.26
Employees202 Current Ratio3.00 Sales Q/Q99.70% Oper. Margin31.80% RSI (14)51.49 Volatility4.09% 5.68%
OptionableYes Debt/Eq0.00 EPS Q/Q-8.80% Profit Margin27.00% Rel Volume0.48 Prev Close38.97
ShortableYes LT Debt/Eq0.00 EarningsNov 11 BMO Payout0.00% Avg Volume477.46K Price38.75
Recom2.00 SMA20-0.17% SMA502.69% SMA2009.65% Volume230,588 Change-0.56%
Nov-12-14Reiterated RBC Capital Mkts Outperform $51 → $53
Nov-12-14Downgrade Oppenheimer Outperform → Perform $40
Oct-02-14Initiated RBC Capital Mkts Outperform $51
Aug-14-13Reiterated Oppenheimer Outperform $23 → $27
Jul-31-13Initiated Oppenheimer Outperform $23
Nov-21-14 10:30AM  Insider Trading Alert - INSY, LNKD And IMPV Traded By Insiders at TheStreet
Nov-19-14 04:30PM  Insys Therapeutics to Present at 26th Annual Piper Jaffray Healthcare Conference Marketwired
01:04PM  INSYS THERAPEUTICS, INC. Financials EDGAR Online Financials
Nov-17-14 05:42AM  Weakness Seen in Vascular Solutions (VASC): Stock Plunges 22.2% Zacks
Nov-15-14 06:33AM  The most dangerous medical marijuana myth at USA TODAY
Nov-14-14 06:05AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
Nov-12-14 10:00AM  Insys Therapeutics (INSY) Is Weak On High Volume Today at TheStreet
07:43AM  Insys Therapeutics downgraded by Oppenheimer Briefing.com
06:07AM  INSYS THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
05:27AM  INSYS Therapeutics (INSY) in Focus: Stock Rises 12% Zacks
Nov-11-14 06:02PM  Nasdaq stocks posting largest percentage increases AP +12.03%
04:16PM  Dow, S&P 500 close at record on Veterans Day at CNBC
11:33AM  Insys Q3 Beats Estimates, Helping Stock Rebound at Investor's Business Daily
11:04AM  Insys Therapeutics (INSY) Stock Soars Today on Third Quarter Earnings Beat at TheStreet
08:17AM  US stock futures add to gains; D.R. Horton reports at CNBC
08:11AM  Insys Therapeutics posts 3Q profit AP
07:07AM  Q3 2014 Insys Therapeutics Inc Earnings Release - Before Market Open CCBN
Nov-10-14 05:16PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financi EDGAR Online
Oct-31-14 04:08PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi EDGAR Online
Oct-22-14 05:01PM  Biotechs Show Fed Chief's Not Much Of A Stock Analyst at Investor's Business Daily
Oct-16-14 06:01AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Oct-15-14 05:46PM  [$$] FDA Rejects Insys's Dronabinol Application at The Wall Street Journal +6.54%
Oct-06-14 09:00AM  Neutra Corp Doubles but Cannabis Stocks Move Largely Lower Last Week Accesswire -7.05%
Oct-02-14 12:03PM  Insys Therapeutics Up On Bullish Analyst Initiation at Investor's Business Daily +6.93%
Sep-18-14 09:55AM  Cannabis Technologies Looks to Diversify Pipeline with New Hire Accesswire
Sep-12-14 05:11PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online
Sep-03-14 08:00AM  Insys Therapeutics, Inc. Named Arizona Bioscience Company of the Year Business Wire
Aug-26-14 03:30PM  Insys Therapeutics' Cannabidiol Gets Orphan Drug Status Zacks
Aug-25-14 10:17AM  FDA names potential Insys treatment an orphan drug AP
Aug-22-14 09:45AM  Novus Aims to Make Medical Cannabis Affordable Accesswire
Aug-19-14 06:30AM  5 Stocks Jumping on Unusual Volume at TheStreet
Aug-18-14 06:05AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rig EDGAR Online +5.81%
Aug-14-14 06:04AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Aug-12-14 10:53AM  Stocks Stake Out Thin Gains; Intercept, Insys, Autohome Gain at Investor's Business Daily
10:01AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
09:07AM  Stock Futures Hem And Haw; Intercept Pharmaceuticals Soars at Investor's Business Daily
07:07AM  Q2 2014 Insys Therapeutics Inc Earnings Release - Before Market Open CCBN
Aug-11-14 02:33PM  Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment Accesswire +7.64%
Aug-08-14 04:45PM  GW Pharma, Insys Face Off In Cannabis Drug Space at Investor's Business Daily
Jul-16-14 03:40PM  6 stocks to watch at MarketWatch
Jul-11-14 06:34PM  MONDAY DEADLINE: Levi & Korsinsky, LLP Notifies Investors of Class Action Against INSYS Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014 -- INSY PR Newswire
05:02PM  Is This Marijuana Stock GW Pharmaceuticals' Biggest Risk? at Motley Fool
04:17PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against INSYS Therapeutics, Inc. and Certain Officers - INSY Marketwired
Jul-10-14 10:00PM  INSYS 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against INSYS Therapeutics, Inc. - INSY Marketwired
01:58PM  UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against INSYS Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014 Business Wire
Jul-09-14 04:10PM  Insys Completes Study on Dronabinol Oral Solution Zacks
03:55PM  Faruqi & Faruqi, LLP Reminds Investors in INSYS Therapeutics, Inc. (INSY) of Imminent Deadline to Protect Your Rights GlobeNewswire
Jul-08-14 11:36AM  INSYS Therapeutics Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors Business Wire -5.20%
07:00AM  Insys Therapeutics Updates Timing of NDA for Dronabinol Oral Solution Marketwired
Jul-07-14 06:51PM  EQUITY ALERT: Rosen Law Firm Reminds INSYS Therapeutics Investors of Important July 2014 Class Action Deadline -- INSY Marketwired
05:42PM  UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against INSYS Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014 -- INSY Marketwired
Jul-04-14 01:17PM  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In INSYS Therapeutics, Inc. (INSY) To Contact The Firm PR Newswire
Jul-03-14 10:30AM  Insys Therapeutics' Epilepsy Therapy Gains FDA Orphan Drug Status Zacks
Jul-02-14 04:15PM  UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against INSYS Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014 -- INSY GlobeNewswire
07:00AM  Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Dravet Syndrome, a Rare Form of Epilepsy Marketwired
Jul-01-14 10:32AM  INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against INSYS Therapeutics, Inc. Business Wire
04:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline -- INSY GlobeNewswire
Jun-30-14 01:34PM  DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholder Of INSYS Therapeutics, Inc. Of Upcoming Deadline Business Wire
10:58AM  GW Pharma Drug Impresses At Epilepsy Conference at Investor's Business Daily
07:00AM  Insys Therapeutics Reaffirms Second Quarter 2014 Revenue Guidance Marketwired
Jun-25-14 09:12AM  Wednesday's Top Health Care Stories: Aerie, Insys, and Owens & Minor at Motley Fool +6.51%
08:14AM  [$$] Insys: Cannibas-Based Epilepsy Treatment Gets Orphan Drug Status at The Wall Street Journal
07:00AM  Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Rare Form of Epilepsy, Lennox-Gastaut Syndrome Marketwired
Jun-23-14 01:46PM  Shorts Are Piling Into These Stocks. Should You Be Worried?
Jun-20-14 10:30PM  EQUITY ALERT: Rosen Law Firm Reminds INSYS Therapeutics, Inc. Investors of Important Class Action Deadline -- INSY GlobeNewswire
06:04PM  Why Shorts Are Taking Aim at This Marijuana Stock at Motley Fool
09:55AM  Insys Therapeutics (INSY) In A Perilous Reversal at TheStreet
Jun-19-14 09:00PM  INVESTOR ALERT: Those With Losses Exceeding $100,000 From Investment In INSYS Therapeutics, Inc. Are Encouraged to Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire +5.30%
Jun-18-14 02:04PM  5 Stocks With Big Insider Buying at TheStreet
Jun-17-14 04:20PM  GW Pharma Up On Positive Data For Epilepsy Drug at Investor's Business Daily +12.29%
Jun-15-14 01:08PM  Better Marijuana Stock: GW Pharma vs Insys at Motley Fool
Jun-13-14 11:13PM  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in INSYS Therapeutics, Inc. (INSY) to Contact the Firm Marketwired
12:17PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against INSYS Therapeutics, Inc. and Certain Officers - INSY PR Newswire
Jun-10-14 04:43PM  Insys Therapeutics to Present at 9th Annual JMP Securities Healthcare Conference Marketwired
10:32AM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against INSYS Therapeutics, Inc. Business Wire
Jun-09-14 09:34AM  Deadline on July 14, 2014 in Lawsuit for Investors in Insys Therapeutics Inc (INSY) Shares Announced by Shareholders Foundation GlobeNewswire
Jun-06-14 03:11PM  INVESTOR ALERT: Those With Losses Exceeding $100,000 From Investment in INSYS Therapeutics, Inc. are Encouraged to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- INSY GlobeNewswire
09:11AM  Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
Jun-05-14 08:00AM  Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Insys Therapeutics, Inc. Business Wire
Jun-04-14 06:02PM  The 3 Biggest Biotech Crashes in May at Motley Fool
Jun-03-14 06:47AM  Why INSYS Therapeutics (INSY) Could Be Positioned for a Slump Zacks
Jun-02-14 10:39AM  Morgan & Morgan Announces That a Class Action Was Filed Against Insys Therapeutics, Inc. (INSY) GlobeNewswire
Jun-01-14 09:19AM  Insys Therapeutics: 3 Different Insiders Have Purchased Shares During The Last 30 Days at Seeking Alpha
May-30-14 02:03PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline -- INSY GlobeNewswire -6.17%
May-29-14 07:06AM  Insys Therapeutics submits Type II DMF to FDA for CBD API at theflyonthewall.com +5.24%
07:00AM  Insys Therapeutics Submits Drug Master File for Cannabidiol Active Pharmaceutical Ingredient (API) Marketwired
May-28-14 05:33PM  INVESTOR ALERT: Those With Losses Exceeding $100,000 From Investment In INSYS Therapeutics, Inc. Are Encouraged to Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
May-27-14 06:31PM  3 Biotech Stocks Falling Like a Knife: Aegerion, Insys, and Prothena at Motley Fool
10:32AM  INVESTOR ALERT: Class Action Lawsuit Against INSYS Therapeutics, Inc. Announced by Law Offices of Howard G. Smith Business Wire
May-23-14 09:09AM  BMO Capital specialty pharma analyst holds analyst/industry conference call at theflyonthewall.com
May-22-14 07:30AM  Insys Therapeutics to Present at Upcoming Conferences in June Marketwired
May-21-14 05:38PM  INVESTOR ALERT: Those With Losses Exceeding $100,000 From Investment In INSYS Therapeutics, Inc. Are Encouraged to Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit-INSY Thomson Reuters ONE
May-20-14 04:06PM  Lifshitz & Miller Law Firm Announces Investigation of Aeroflex Holding Corp., INSYS Therapeutics, Inc., Lihua International, Inc., Overland Storage, Inc., and The ADT Corporation PR Newswire
12:50PM  Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Insys Therapeutics, Inc. Business Wire
10:32AM  INVESTOR ALERT: Class Action Lawsuit Against INSYS Therapeutics, Inc. Filed By Glancy Binkow & Goldberg LLP Business Wire
06:27AM  Cramer's Mad Money - What Could Go Wrong With AT&T's Takeover Of DirecTV (5/19/14) at Seeking Alpha
May-19-14 07:39AM  INSYS Therapeutics (INSY) in Focus: Stock Rises 5.5% Zacks +11.32%
May-18-14 02:17PM  1 Stock Putting A New Spin on an Old Marijuana Drug at Motley Fool
May-16-14 10:00PM  INSYS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against INSYS Therapeutics, Inc. - INSY GlobeNewswire +5.53%
07:33PM  EQUITY ALERT: Rosen Law Firm Files Class Action Lawsuit Against INSYS Therapeutics, Inc. -- INSY GlobeNewswire
Insys Therapeutics, Inc., a commercial-stage specialty pharmaceutical company, develops and commercializes supportive care products. It focuses on utilizing its proprietary formulation technologies to address the clinical shortcomings of existing commercial pharmaceutical products. The company markets Subsys, a proprietary sublingual fentanyl spray for breakthrough pain in opioid-tolerant cancer patients; and Dronabinol Oral Solution, a proprietary orally administered liquid formulation of dronabinol. It offers its Subsys through its incentive-based commercial sales force. The company also provides Dronabinol SG Capsule, a generic equivalent to Marinol (dronabinol), an approved second-line treatment for chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. Insys Therapeutics, Inc. was incorporated in 1990 and is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FOURTEAU PATRICKDirectorNov 19Sale39.1125,000977,67380,000Nov 20 05:43 PM
Babich Michael LPresident and CEONov 04Option Exercise2.367,50017,700177,295Nov 04 07:02 PM
Babich Michael LPresident and CEONov 04Sale37.277,500279,504169,795Nov 04 07:02 PM
Babich Michael LPresident and CEONov 03Option Exercise2.3672,500171,100242,295Nov 04 07:02 PM
Babich Michael LPresident and CEONov 03Sale38.8072,5002,813,223169,795Nov 04 07:02 PM
Babich Michael LPresident and CEOOct 21Option Exercise3.5420,00070,800189,795Oct 22 04:50 PM
Babich Michael LPresident and CEOOct 21Sale40.1720,000803,404169,795Oct 22 04:50 PM
Babich Michael LPresident and CEOOct 16Option Exercise3.255,00016,250165,562Oct 16 05:34 PM
STANLEY THEODORE HDirectorAug 13Buy33.933,000101,8005,100Aug 15 12:51 PM
KAPOOR JOHN NDirectorJun 16Buy26.135,000130,62621,174,805Jun 18 10:39 AM
KAPOOR JOHN NDirectorJun 13Buy25.445,000127,20521,169,805Jun 17 12:23 PM
KAPOOR JOHN NDirectorJun 12Buy24.8420,000496,76221,164,805Jun 16 12:57 PM
KAPOOR JOHN NDirectorJun 11Buy24.5420,000490,80021,144,805Jun 13 12:39 PM
KAPOOR JOHN NDirectorMay 19Option Exercise9.2915,991148,48215,991May 20 06:38 PM
STANLEY THEODORE HDirectorMay 19Buy24.831,00024,8306,100May 19 03:22 PM
BAKER DARRYL SChief Financial OfficerMay 15Option Exercise7.2610,00072,60014,687May 16 02:12 PM
Babich Michael LPresident and CEOMay 15Option Exercise3.257,50024,375150,562May 16 02:09 PM
FOURTEAU PATRICKDirectorMay 15Buy22.777,500170,775105,000May 15 07:42 PM
MEYER STEVEN JDirectorMay 15Buy21.385,000106,9005,000May 15 07:39 PM
STANLEY THEODORE HDirectorMay 15Buy20.983,00062,9405,100May 19 03:22 PM
Babich Michael LPresident and CEOMar 18Option Exercise2.9590,000265,72895,375Mar 18 06:54 PM
STANLEY THEODORE HDirectorMar 13Buy71.9530021,5851,400Mar 13 04:18 PM
STANLEY THEODORE HDirectorMar 12Buy73.4020014,6801,100Mar 13 04:18 PM
STANLEY THEODORE HDirectorMar 06Buy74.2620014,853900Mar 06 07:05 PM
Babich Michael LPresident and CEOMar 05Option Exercise1.84212,125390,184293,807Mar 06 07:02 PM
Dillaha LarryChief Medical OfficerMar 05Option Exercise3.18149,932476,836153,057Mar 06 07:03 PM
STANLEY THEODORE HDirectorMar 05Buy77.2920015,459700Mar 06 07:05 PM
Babich Michael LPresident and CEOMar 05Sale74.58288,43221,512,1125,375Mar 06 07:02 PM
Dillaha LarryChief Medical OfficerMar 05Sale74.57149,93211,179,7623,125Mar 06 07:03 PM